Veritone Alpha, Inc.
USPTO PatentsView assignee record - 15 granted patents across 15 technology areas, recorded in grant years 2018–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G05B (Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements).
The verdict
According to USPTO PatentsView, Veritone ranks #19,323 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 15 technology areas.
- #19,323
- of 49,997 US assignees by volume
- Top 36%
- by Innovation Score (40.3/100)
- 25.5
- avg claims per patent
- +50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R19323 · US Corporation #19,323 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 15 grants
- MID-PACK #19,323/49,997
- PHOTO-FINISH Vascular Imaging
- CPC-FOCUS G05B · 15 areas
- INNOV-PAR 40.3/100
- CLAIMS-DENSE 25.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Vascular Imaging Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Veritone’s 40.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Veritone
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Hewlett-Packard… · near
Hewlett-Packard… · near
40 score
- Menarini Silicon… · near
Menarini Silicon… · near
40 score
- Roadtec · near
Roadtec · near
40 score
- Veritone Alpha · this assignee
Veritone Alpha · this assignee
40 score
- Wintek · near
Wintek · near
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Veritone's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Veritone?
Each dot is one of Veritone’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Veritone’s own 25.5 claims/patent is ABOVE the 16.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Veritone's grants concentrate
Veritone Alpha, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 93.3% of grants classified under G05B (Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2023. By volume, Veritone sits between Vascular Imaging Corporation and Vigilent Corporation.
Veritone's three-year grant acceleration
Veritone Alpha, Inc. shows 3 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Veritone's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Vascular Imaging
Vascular Imaging Corporation
15 patents
- Vaxxas Pty
Vaxxas Pty Limited
15 patents
- Vedanta Bioscienc…
Vedanta Biosciences, Inc.
15 patents
- Venturemed Group
VentureMed Group, Inc.
15 patents
- Verona Pharma
Verona Pharma PLC
15 patents
- Vi-jon
Vi-Jon, LLC
15 patents
- Vicarious FPC
Vicarious FPC, Inc.
15 patents
- Vigilent
Vigilent Corporation
15 patents
- Veritone Alpha ◀
Veritone Alpha, Inc.
15 patents
What this shows Veritone holds 15 patents at rank #19,324, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Veritone
By rank, the assignees closest to #19,324 in granted patent volume.
- Vascular Imaging Corporation #19,320 · 15 patents
- Vaxxas Pty Limited #19,321 · 15 patents
- Vedanta Biosciences, Inc. #19,322 · 15 patents
- VentureMed Group, Inc. #19,323 · 15 patents
- Verona Pharma PLC #19,325 · 15 patents
- Vi-Jon, LLC #19,326 · 15 patents
- Vicarious FPC, Inc. #19,327 · 15 patents
- Vigilent Corporation #19,328 · 15 patents
Leaders in G05B (Control OR Regulating Systems IN General)
Other assignees with the most granted patents in Veritone's primary technology class.
- Fanuc Corporation 1,835 in class
- Siemens Aktiengesellschaft 954 in class
- Rockwell Automation Technologies, Inc. 837 in class
- Mitsubishi Electric Corporation 731 in class
- General Electric Company 632 in class
- Honeywell International Inc. 629 in class
- Omron Corporation 590 in class
- The Boeing Company 472 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Veritone, neither rank-band nor same-CPC leaders (those blocks stay above). In G05B (Control OR Regulating Systems IN General), Veritone ranks #332 of 3,455 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (40 here).
Veritone's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 36% higher than 64% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 13.3% |
| 2019 | 4 | 26.7% |
| 2020 | 3 | 20.0% |
| 2021 | 3 | 20.0% |
| 2022 | 2 | 13.3% |
| 2023 | 1 | 6.7% |
Which technologies does Veritone Alpha, Inc. patent most?
Top 15 of 15 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Veritone Alpha, Inc.'s patent record in context - here's where to go next.
- Veritone Alpha, Inc.'s lead technology class is G05B (Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements), 93.3% of its portfolio - see every assignee active in that class. Explore G05B
- Ranked #19,323 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Veritone Alpha, Inc. against Vascular Imaging Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.